De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Ratchaphruek Hospital Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Teerawat Srinakarin

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	no data
Eigendom CEO	14.4%
Management gemiddelde ambtstermijn	3.1yrs
Gemiddelde ambtstermijn bestuur	less than a year

Recente managementupdates

Recent updates

CEO

Teerawat Srinakarin

no data

Tenure

Dr. Teerawat Srinakarin, MD serves as Chief Executive Officer and Director at Ratchaphruek Hospital Public Company Limited.

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Sudhon Sriyapant	Chairman of the Board & President	4.5yrs	geen gegevens	2.67% THB 84.6m
Teerawat Srinakarin	CEO & Director	no data	geen gegevens	14.36% THB 454.8m
Supaporn Sukhee	Director of Accounting & Finance	no data	geen gegevens	geen gegevens
Weerada Thongtranon	Director of Information	2.4yrs	geen gegevens	geen gegevens
Chularat Sirisingh	Company Secretary & Investor Relations	3.1yrs	geen gegevens	geen gegevens

3.1yrs

Gemiddelde duur

Ervaren management: Het managementteam van RPH wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.1 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Sudhon Sriyapant	Chairman of the Board & President	4.5yrs	geen gegevens	2.67% THB 84.6m
Teerawat Srinakarin	CEO & Director	no data	geen gegevens	14.36% THB 454.8m
Vallop Laopaiboon	Vice Chairman of the Board	2.5yrs	geen gegevens	11.64% THB 368.5m
Srichai Krusan	Director	no data	geen gegevens	1.17% THB 37.1m
Suphan Srithamma	Director	no data	geen gegevens	geen gegevens
Vorathep Rangchaikul	Independent Director	3.7yrs	geen gegevens	geen gegevens
Sirikul Laukaikul	Independent Director	less than a year	geen gegevens	geen gegevens
Tina Singhsacha	Independent Director	less than a year	geen gegevens	geen gegevens
Orawan Sirirattanawong	Independent Director	less than a year	geen gegevens	geen gegevens
Vairoj Jindamaneepitak	Independent Director	less than a year	geen gegevens	geen gegevens

0.7yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van RPH wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 0.7 jaar), wat duidt op een nieuw bestuur.

Ratchaphruek Hospital Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Ratchaphruek Hospital Public Company Limited Appoints Tina Singhsacha as Member of Risk Management Committee

Ratchaphruek Hospital Public Company Limited Appoints Tina Singhsacha as Member of Risk Management Committee

High number of new directors

Ratchaphruek Hospital Public Company Limited Announces Audit Committee Changes

Ratchaphruek Hospital Public Company Limited Announces Termination of Supaporn Sukhee as Deputy Accounting and Financial Director

Less than half of directors are independent

Recent updates

Upcoming dividend of ฿0.11 per share

First half dividend of ฿0.11 announced

Second quarter 2024 earnings released: EPS: ฿0.064 (vs ฿0.082 in 2Q 2023)

Ratchaphruek Hospital Public Company Limited Appoints Tina Singhsacha as Member of Risk Management Committee

Ratchaphruek Hospital Public Company Limited Appoints Tina Singhsacha as Member of Risk Management Committee

First quarter 2024 earnings released: EPS: ฿0.071 (vs ฿0.068 in 1Q 2023)

High number of new directors

Ratchaphruek Hospital Public Company Limited Announces Audit Committee Changes

Upcoming dividend of ฿0.19 per share

Full year 2023 earnings released: EPS: ฿0.34 (vs ฿0.53 in FY 2022)

Ratchaphruek Hospital Public Company Limited Proposes Dividend for 2023, Payable on May 15, 2024

Third quarter 2023 earnings released: EPS: ฿0.12 (vs ฿0.10 in 3Q 2022)

Upcoming dividend of ฿0.11 per share at 3.5% yield

Ratchaphruek Hospital Public Company Limited Announces Termination of Supaporn Sukhee as Deputy Accounting and Financial Director

Second quarter 2023 earnings released: EPS: ฿0.082 (vs ฿0.10 in 2Q 2022)

First quarter 2023 earnings released: EPS: ฿0.068 (vs ฿0.33 in 1Q 2022)

Upcoming dividend of ฿0.15 per share at 5.7% yield

Price target decreased by 26% to ฿5.50

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: ฿0.10 (vs ฿0.27 in 3Q 2021)

Upcoming dividend of ฿0.20 per share

Ratchaphruek Hospital Public Company Limited Announces Management Appointments

Second quarter 2022 earnings released: EPS: ฿0.10 (vs ฿0.026 in 2Q 2021)

Ratchaphruek Hospital Public Company Limited Announces Cash Dividend for the Operating Period from January 1, 2022, to June 30, 2022, Payable on September 1, 2022

Investor sentiment improved over the past week

Consensus EPS estimates increase by 16%

First quarter 2022 earnings: EPS exceeds analyst expectations

Consensus revenue estimates increase by 13%

Less than half of directors are independent

Upcoming dividend of ฿0.25 per share

Consensus EPS estimates increase by 65%

Now 20% undervalued

Ratchaphruek Hospital Public Company Limited Appoints Mr. Adisorn Thavornthanasarn as New Independent Director

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Third quarter 2021 earnings released: EPS ฿0.27 (vs ฿0.038 in 3Q 2020)

Company Secretary. CFO & Investor Relations Chatsiam Jariyawattanagulgit has left the company

Price target increased to ฿7.45

Upcoming dividend of ฿0.05 per share

Consensus EPS estimates increase to ฿0.21

Second quarter 2021 earnings released: EPS ฿0.026 (vs ฿0.007 in 2Q 2020)

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS ฿0.035 (vs ฿0.055 in 1Q 2020)

Upcoming dividend of ฿0.10 per share

Ratchaphruek Hospital Public Company Limited Announces Executive Appointments

Revenue and earnings beat expectations

Full year 2020 earnings released: EPS ฿0.17 (vs ฿0.18 in FY 2019)

Ratchaphruek Hospital Public Company Limited Announces Appointment of Mr. Vorathep Rangchaikul as Director

Ratchaphruek Hospital Public Company Limited Announces the Resignation of Mr. Vanchai Wattanasapt as Director and Audit Committee

Market bids up stock over the past week

New 90-day high: ฿5.55

Third quarter 2020 earnings released: EPS ฿0.038

New 90-day high: ฿5.50

Analysts lower EPS estimates to ฿0.12

Earnings released

CEO

Tenure

Leiderschapsteam

Gemiddelde duur

Bestuursleden

Gemiddelde duur